Found: 7
Select item for more details and to access through your institution.
Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97404-2
- By:
- Publication type:
- Article
Repurposing of 8‐Hydroxyquinoline‐Based Butyrylcholinesterase and Cathepsin B Ligands as Potent Nonpeptidic Deoxyribonuclease I Inhibitors.
- Published in:
- ChemMedChem, 2022, v. 17, n. 5, p. 1, doi. 10.1002/cmdc.202100694
- By:
- Publication type:
- Article
Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
- Published in:
- Scientific Reports, 2016, p. 39495, doi. 10.1038/srep39495
- By:
- Publication type:
- Article
FROM SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS TO MULTI-TARGET-DIRECTED LIGANDS AS LEAD COMPOUNDS FOR ALZHEIMER'S DISEASE.
- Published in:
- Military Medical Science Letters / Vojenské zdravotnické Listy, 2018, v. 87, p. 70
- By:
- Publication type:
- Article
Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 4, p. 505, doi. 10.1007/s11307-021-01584-2
- By:
- Publication type:
- Article
A Simple and Effective Synthesis of 3- and 4-((Phenylcarbamoyl)oxy)benzoic Acids.
- Published in:
- Acta Chimica Slovenica, 2020, v. 67, n. 3, p. 940, doi. 10.17344/acsi.2020.6006
- By:
- Publication type:
- Article
Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease.
- Published in:
- Theranostics, 2021, v. 11, n. 13, p. 6542, doi. 10.7150/thno.54589
- By:
- Publication type:
- Article